Keyword: University of Washington
Guardant Health has moved to acquire Bellwether Bio, which focuses on early cancer diagnostics that tap into the epigenomics of cell-free DNA.
Scientists have used computer programs to design a protein that looks like natural IL-2 but that lacks the toxicities of IL-2 cancer drugs.
Insights into how bacteria hibernate and use metals to evade destruction by antibiotics could be useful in drug development.
An expanded understanding of the genetics behind breast cancer and blood pressure could improve treatments.
With the new capital, NeoTherma will test its VectRx thermal oncology treatment platform in humans.
The study showed that the pill suppressed levels of three hormones required for sperm production.
Biotech developments over the past week include promising data from a human trial of male contraception and a new strategy to protect against malaria.
University of Washington scientists are using stem cells from Alzheimer’s patients to study two toxic proteins implicated in Alzheimer's disease.
Takeda has added another early-stage research partnership as it reboots its R&D operations, this time teaming with two Seattle-based academic centers.
A smartphone app, a pair of glasses and a 3D-printed box could spot jaundice, an early symptom of pancreatic cancer.